Home › Therapeutic areas › Metabolic › Wolfram Syndrome
Wolfram Syndrome (1 companies)
Companies with an active program in Wolfram Syndrome.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals | MetabolicNeurology Rare | 1 | Phase 3 | $3.79B | 5 |
No companies match.